Core Scientific (CORZ) Free Cash Flow (2021 - 2026)

Core Scientific has disclosed Free Cash Flow across 6 years of filings, most recently posting -$583.9 million for Q2 2026.

• In Q2 2026, Free Cash Flow fell 569.06% year-over-year to -$583.9 million; the TTM figure through Jun 2026 stood at -$957.7 million (down 273.08% YoY), while the FY2025 annual figure was -$450.8 million, down 765.74% from the prior year.
• Free Cash Flow came in at -$583.9 million for Q2 2026 at Core Scientific, down from -$139.3 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $39.6 million in Q2 2022 to a low of -$583.9 million in Q2 2026.
• Average Free Cash Flow over 5 years is -$75.3 million, with a median of -$24.8 million recorded in 2022.
• Year-over-year, Free Cash Flow surged 141.5% in 2023 and tumbled 4419.89% in 2025.
• Over 5 years, Free Cash Flow stood at -$24.2 million in 2022, then surged by 141.5% to $10.1 million in 2023, then plunged by 248.67% to -$15.0 million in 2024, then tumbled by 714.14% to -$121.7 million in 2025, then plunged by 379.67% to -$583.9 million in 2026.
• Per Business Quant data, the three most recent Free Cash Flow figures were -$583.9 million in Q2 2026, -$139.3 million in Q1 2026, and -$121.7 million in Q4 2025.